This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Universitá Degli Studi Di Genova. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Maurizio Balestrino: Innovator in Medicinal Chemistry
Introduction
Maurizio Balestrino is a notable inventor based in Genoa, Italy. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on creatine derivatives. His research focuses on developing therapeutic agents that can aid in cancer treatment.
Latest Patents
Balestrino holds a patent for a creatine derivative known as (Boc)-creatine. This compound is utilized as a medicament, specifically in therapeutic antitumor treatments. His patent represents a crucial advancement in the search for effective cancer therapies.
Career Highlights
Maurizio Balestrino is affiliated with the Università Degli Studi Di Genova, where he conducts his research and development. His work has garnered attention for its potential impact on cancer treatment, showcasing his dedication to improving patient outcomes through innovative solutions.
Collaborations
Balestrino collaborates with esteemed colleagues such as Patrizia Garbati and Enrico Adriano. These partnerships enhance the research environment and contribute to the advancement of their shared goals in medicinal chemistry.
Conclusion
Maurizio Balestrino's contributions to the field of medicinal chemistry, particularly through his patent on (Boc)-creatine, highlight his role as an innovator dedicated to improving therapeutic options for cancer treatment. His work continues to inspire advancements in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile